$CIEN insiders have traded $CIEN stock on the open market 34 times in the past 6 months. Of those trades, 0 have been purchases and 34 have been sales. Here’s a ...

Palantir Technologies ( PLTR 1.44%) shares have advanced 550% since January 2024. For context, it was the best performing ...

$PCTY insiders have traded $PCTY stock on the open market 524 times in the past 6 months. Of those trades, 0 have been purchases and 524 have been sales. Here’s a ...

Most footwear and apparel companies would see a six-month lead time as a dream as the industry has consistently viewed 18 ...

Blackstone is exploring a $3 billion sale of Sphera, a sustainability software and consulting services provider, according to ...

The biotech’s Huntingtin-targeting molecule lowered blood levels of the protein and elicited functional improvements in ...

CRISPR Therapeutics’ partner Vertex reported that more than 65 treatment centers have been activated for the gene therapy ...

May 08, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will participate in the William Blair Growth Stock Conference on ...

William Blair values Zillow at 8 times 2025 gross profit, 25 times adjusted EBITDA, and 33 times free cash flow. Related articles TD Cowen upgrades Fidelity National to ’Buy’ on cleaner model ...

ASGN Incorporated (NYSE:ASGN – Free Report) – Stock analysts at William Blair decreased their Q2 2025 EPS estimates for shares of ASGN in a note issued to investors on Thursday, April 24th.

As previously reported, William Blair analyst Max Smock downgraded Medpace (MEDP) to Market Perform from Outperform. While admitting to being “late,” the firm contends it is time to downgrade ...

William Blair downgraded Medpace (MEDP) to Market Perform from Outperform. Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search ...